This study investigates hepatocellular carcinoma and pancreatic tumors. The purpose of this study is to explore specific metabolic signatures that could be linked to these conditions.
The study evaluates the potential for identifying metabolic markers that could be significant for prognosis and treatment planning. It looks at how tumor cells use nutrients differently than normal cells, which may be connected to cancer characteristics.
- Who can participate: Adults aged 18 or older with liver or pancreatic cancer who have provided informed consent are eligible.
- Study details: Participants will provide tumor tissue samples for analysis. A placebo is not involved in this study.